N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142948 |
| CAS No | NA |
| Mol.F. | C19H27ClN4O5S |
| Mol.Wt. | 459 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142949 |
| CAS No | NA |
| Mol.F. | C19H27ClN4O5S |
| Mol.Wt. | 459 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142950 |
| CAS No | NA |
| Mol.F. | C19H26ClN5O6S |
| Mol.Wt. | 488 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142951 |
| CAS No | NA |
| Mol.F. | C16H20ClN5O2 |
| Mol.Wt. | 349.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142952 |
| CAS No | NA |
| Mol.F. | C16H21ClN4O2 |
| Mol.Wt. | 336.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142953 |
| CAS No | NA |
| Mol.F. | C8H10N4O5S2 |
| Mol.Wt. | 306.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142954 |
| CAS No | NA |
| Mol.F. | C7H5Cl2N5O6S2 |
| Mol.Wt. | 390.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142955 |
| CAS No | NA |
| Mol.F. | C7H6Cl2N4O5S2 |
| Mol.Wt. | 361.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142956 |
| CAS No | NA |
| Mol.F. | C15H15Cl2N7O9S4 |
| Mol.Wt. | 636.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142957 |
| CAS No | NA |
| Mol.F. | C7H5ClN4O5S2 |
| Mol.Wt. | 324.71 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142958 |
| CAS No | NA |
| Mol.F. | C6H4ClN5O5S2 |
| Mol.Wt. | 325.70 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142959 |
| CAS No | NA |
| Mol.F. | C7H6ClN3O3S |
| Mol.Wt. | 247.65 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142960 |
| CAS No | NA |
| Mol.F. | C12H16N2O3 |
| Mol.Wt. | 236.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142961 |
| CAS No | NA |
| Mol.F. | C14H20N2O6 |
| Mol.Wt. | 312.32 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142962 |
| CAS No | NA |
| Mol.F. | C27H37N3O7 |
| Mol.Wt. | 515.61 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142963 |
| CAS No | NA |
| Mol.F. | C14H18N2O5 |
| Mol.Wt. | 294.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |